Abbott Laboratories v. Gardner

From Wikisource
Jump to: navigation, search

Abbott Laboratories v. Gardner
by the Supreme Court of the United States
Abbott Laboratories v. Gardner, 387 U.S. 136 (1967), was a case heard before the United States Supreme Court. Abbott Laboratories held that drug companies were not prohibited by the ripeness doctrine from challenging a U.S. Food and Drug Administration (FDA) regulation requiring a prescription drug's generic name to appear on all related printed materials. The government argued that the case was not ripe because the regulation had yet to be enforced; however, that argument failed where prosecution was likely and there was substantial hardship to denying a pre-enforcement challenge to the statute. — Excerpted from Abbott Laboratories v. Gardner on Wikipedia, the free encyclopedia.
Court Documents
Opinion of the Court
Wikipedia-logo-v2.svg Wikipedia article

United States Supreme Court

387 U.S. 136


 Argued: Jan. 16, 1967. --- Decided: May 22, 1967

Gerhard A. Gesell, Washington, D.C., for petitioners.

Nathan Lewin, Washington, D.C., for respondents.

Mr. Justice HARLAN delivered the opinion of the Court.


This work is in the public domain in the United States because it is a work of the United States federal government (see 17 U.S.C. 105).